Heart failure drug showdown: Once-a-Day pill tested against Twice-a-Day standard
NCT ID NCT03509545
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a once-daily dose of Torsemide (a water pill) works as well as the standard twice-daily Furosemide in heart failure patients. The goal was to see how much sodium the body gets rid of and if body weight changes. The study was stopped early and included 20 adults on a stable dose of Furosemide.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGESTIVE HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Syngene International
Bangalore, Karnataka, 560099, India